EMEA: marketing authorisation of Neupopeg (pegfilgrastim) withdrawed

Public statement┬ádated 16 December 2008: PUBLIC STATEMENT ON Neupopeg (pegfilgrastim) WITHDRAWAL OF THE MARKETING AUTHORISATION IN THE EUROPEAN UNION On 22 August 2002 the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Neupopeg, pegfilgrastim, which had been approved for the┬áreduction in the duration of neutropenia and the incidence […]